Literature DB >> 19825003

Flat epithelial atypia and atypical ductal hyperplasia: carcinoma underestimation rate.

Anna Ingegnoli1, Cecilia d'Aloia, Antonia Frattaruolo, Lara Pallavera, Eugenia Martella, Girolamo Crisi, Maurizio Zompatori.   

Abstract

This study was carried out to determine the underestimation rate of carcinoma upon surgical biopsy after a diagnosis of flat epithelial atypia and atypical ductal hyperplasia and 11-gauge vacuum-assisted breast biopsy. A retrospective review was conducted of 476 vacuum-assisted breast biopsy performed from May 2005 to January 2007 and a total of 70 cases of atypia were identified. Fifty cases (71%) were categorized as pure atypical ductal hyperplasia, 18 (26%) as pure flat epithelial atypia and two (3%) as concomitant flat epithelial atypia and atypical ductal hyperplasia. Each group were compared with the subsequent open surgical specimens. Surgical biopsy was performed in 44 patients with atypical ductal hyperplasia, 15 patients with flat epithelial atypia, and two patients with flat epithelial atypia and atypical ductal hyperplasia. Five cases of atypical ductal hyperplasia were upgraded to ductal carcinoma in situ, three cases of flat epithelial atypia yielded one ductal carcinoma in situ and two cases of invasive ductal carcinoma, and one case of flat epithelial atypia/atypical ductal hyperplasia had invasive ductal carcinoma. The overall rate of malignancy was 16% for atypical ductal hyperplasia (including flat epithelial atypia/atypical ductal hyperplasia patients) and 20% for flat epithelial atypia. The presence of flat epithelial atypia and atypical ductal hyperplasia at biopsy requires careful consideration, and surgical excision should be suggested.

Entities:  

Mesh:

Year:  2009        PMID: 19825003     DOI: 10.1111/j.1524-4741.2009.00850.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  14 in total

1.  Early Breast Cancer Precursor Lesions: Lessons Learned from Molecular and Clinical Studies.

Authors:  Hans-Peter Sinn; Zeinab Elsawaf; Birgit Helmchen; Sebastian Aulmann
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

2.  Upgrade Rate of Pure Flat Epithelial Atypia Diagnosed at Core Needle Biopsy: A Systematic Review and Meta-Analysis.

Authors:  Rifat A Wahab; Su-Ju Lee; Margaret E Mulligan; Bin Zhang; Mary C Mahoney
Journal:  Radiol Imaging Cancer       Date:  2021-01-22

3.  Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH).

Authors:  Keiko Tsuchiya; Naoko Mori; David V Schacht; Deepa Sheth; Gregory S Karczmar; Gillian M Newstead; Hiroyuki Abe
Journal:  J Magn Reson Imaging       Date:  2017-03-10       Impact factor: 4.813

Review 4.  Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review.

Authors:  Kelly L Mooney; Lawrence W Bassett; Sophia K Apple
Journal:  Mod Pathol       Date:  2016-08-19       Impact factor: 7.842

5.  BRACS: A Dataset for BReAst Carcinoma Subtyping in H&E Histology Images.

Authors:  Nadia Brancati; Anna Maria Anniciello; Pushpak Pati; Daniel Riccio; Giosuè Scognamiglio; Guillaume Jaume; Giuseppe De Pietro; Maurizio Di Bonito; Antonio Foncubierta; Gerardo Botti; Maria Gabrani; Florinda Feroce; Maria Frucci
Journal:  Database (Oxford)       Date:  2022-10-17       Impact factor: 4.462

Review 6.  Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?

Authors:  Marco Lucioni; Chiara Rossi; Pascal Lomoro; Francesco Ballati; Marianna Fanizza; Alberta Ferrari; Carlos A Garcia-Etienne; Emanuela Boveri; Giulia Meloni; Maria Grazia Sommaruga; Elisa Ferraris; Angioletta Lasagna; Elisabetta Bonzano; Marco Paulli; Adele Sgarella; Giuseppe Di Giulio
Journal:  Eur Radiol       Date:  2020-08-20       Impact factor: 5.315

7.  Analysis of Clinical and Pathologic Factors of Pure, Flat Epithelial Atypia on Core Needle Biopsy to Aid in the Decision of Excision or Observation.

Authors:  John S Berry; Alfred F Trappey; Timothy J Vreeland; Adam R Pattyn; Guy T Clifton; Elizabeth A Berry; Erika J Schneble; Aaron D Kirkpatrick; Jeffrey S Saenger; George E Peoples
Journal:  J Cancer       Date:  2016-01-01       Impact factor: 4.207

8.  Validation of a scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia using an ultrasound-guided core needle biopsy.

Authors:  Jisun Kim; Wonshik Han; Eun-Young Go; Hyeong-Gon Moon; Soo Kyung Ahn; Hee-Chul Shin; Jee-Man You; Jung Min Chang; Nariya Cho; Woo Kyung Moon; In Ae Park; Dong-Young Noh
Journal:  J Breast Cancer       Date:  2012-12-31       Impact factor: 3.588

9.  First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).

Authors:  Christoph J Rageth; Elizabeth Am O'Flynn; Christopher Comstock; Claudia Kurtz; Rahel Kubik; Helmut Madjar; Domenico Lepori; Gert Kampmann; Alexander Mundinger; Astrid Baege; Thomas Decker; Stefanie Hosch; Christoph Tausch; Jean-François Delaloye; Elisabeth Morris; Zsuzsanna Varga
Journal:  Breast Cancer Res Treat       Date:  2016-08-13       Impact factor: 4.872

10.  Assessment of Breast Specimens With or Without Calcifications in Diagnosing Malignant and Atypia for Mammographic Breast Microcalcifications Without Mass: A STARD-Compliant Diagnostic Accuracy Article.

Authors:  Yun-Chung Cheung; Yu-Hsiang Juan; Shir-Hwa Ueng; Yung-Feng Lo; Pei-Chin Huang; Yu-Ching Lin; Shin-Cheh Chen
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.